These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14507079)

  • 21. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 23. New book about vaccine safety.
    Offit PA
    Pediatrics; 2008 Oct; 122(4):871-2. PubMed ID: 18829814
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccine adverse event reporting system reporting source: a possible source of bias in longitudinal studies.
    Goodman MJ; Nordin J
    Pediatrics; 2006 Feb; 117(2):387-90. PubMed ID: 16452357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serious adverse events in Norplant users related to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Chez RA
    Obstet Gynecol; 1995 Jul; 86(1):154-5. PubMed ID: 7784014
    [No Abstract]   [Full Text] [Related]  

  • 26. The black box warning.
    Abourjaily HM; Rosenberg M
    J Mass Dent Soc; 2002; 51(3):54-6. PubMed ID: 12380043
    [No Abstract]   [Full Text] [Related]  

  • 27. Vioxx's history and the need for better procedures and better testing.
    Gilhooley M
    Seton Hall Law Rev; 2007; 37(4):941-68. PubMed ID: 18363218
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA "black box" labeling.
    Meyer RJ
    Ann Emerg Med; 2003 Apr; 41(4):559-60. PubMed ID: 12658256
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-cultural miscommunication.
    Kang-Yum E
    Hastings Cent Rep; 1996; 26(3):46. PubMed ID: 8736674
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry.
    Mayans MV; Robertson SE; Duclos P
    Bull World Health Organ; 2000; 78(9):1167. PubMed ID: 11019467
    [No Abstract]   [Full Text] [Related]  

  • 32. Guidelines for reporting adverse events associated with vaccine products. Division of Immunization, Bureau of Infectious Diseases, Laboratory Center for Disease Control.
    Can Commun Dis Rep; 2000 Feb; 26 Suppl 1():I-IV, 1-18. PubMed ID: 11055081
    [No Abstract]   [Full Text] [Related]  

  • 33. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmarketing modifications in the safety labeling of the new antiepileptics.
    Buck ML; Gurka MJ; Goodkin HP
    Neurology; 2007 May; 68(18):1536-7. PubMed ID: 17470758
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse drug reaction reporting.
    Somberg JC
    Am J Ther; 2000 Aug; 7(4):227-8. PubMed ID: 11486155
    [No Abstract]   [Full Text] [Related]  

  • 36. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
    Moore TJ; Cohen MR; Furberg CD
    Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring for adverse drug events.
    Kennedy DL; Goldman SA
    Am Fam Physician; 1997 Nov; 56(7):1718, 1721. PubMed ID: 9371003
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of adverse drug reaction reporting in veterinary and human medicine.
    Bukowski JA; Wartenberg D
    J Am Vet Med Assoc; 1996 Jul; 209(1):40-5. PubMed ID: 8926206
    [No Abstract]   [Full Text] [Related]  

  • 39. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA guidance document on monitoring delayed adverse events a good first start.
    Williams DA
    Mol Ther; 2005 Dec; 12(6):991-2. PubMed ID: 16271514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.